2026年2月13日 美国东部时间上午11:45 / 福克斯新闻
福克斯独家消息： 一名共和党参议员正要求美国食品药品监督管理局（FDA）调查，非法中国成分是否正流入美国减肥药中。
来自阿肯色州的共和党参议员汤姆·科顿呼吁FDA专员马丁·马卡里调查，未经监管的非法中国活性药物成分已在多大程度上渗透美国供应链——以及它们是否已出现在受欢迎的减肥药中。
“中国介入美国制药供应链，不仅带来国家安全风险，也对美国患者构成重大健康风险，”科顿在写给马卡里的信中写道，该信首先被福克斯新闻数字版获取。
果冻卷（Jelly Roll）的妻子称减肥药致其陷入“最严重自杀性抑郁”
来自阿肯色州的共和党参议员汤姆·科顿呼吁FDA专员马丁·马卡里调查，非法和未经监管的中国药物成分在美国的分布范围，以及它们在非FDA监管减肥药中的分布情况。（比尔·克拉克/CQ Roll Call, Inc. 授权盖蒂图片社）
科顿的担忧源于FDA和美国海关与边境保护局（CBP）近期的报告：2023年9月至2025年1月期间，当局截获了195批非法活性药物成分。
他指出，这些成分“可能被用于合成减肥药”并进入美国市场。在这些被截获的货物中，约有60批来自中国和香港。
“据估计，截至2026年1月，多达150万美国患者可能正在使用未经监管的合成减肥药，这些药物可能含有来自中国制造商的潜在危险成分，”科顿写道。
审视来自共产主义中国的下一个威胁：我们的医疗保健系统
美国人转向风险较高的非监管卖家购买GLP-1减肥药。（iStock）
这些成分通常用于GLP-1减肥药的合成版本中，这类药物被宣传为FDA批准药物（如Ozempic和Wegovy）的替代品。
本月早些时候，美国卫生与公众服务部宣布将以“可能违反《联邦食品、药品和化妆品法案》”为由，将远程医疗公司Hims & Hers移交司法部，因其计划销售一种未经FDA批准的合成减肥药。
马卡里同样表示，FDA将“采取果断措施，限制 intended for use in non-FDA-approved compounded drugs（用于非FDA批准的合成药物中的）GLP-1活性药物成分（APIs），这些成分正被包括Hims & Hers在内的公司以及其他配药药房大规模营销为FDA批准药物的替代品。”
费特曼背离民主党，称政党在国土安全部停摆对峙中将政治置于国家利益之上
该公司上周宣布，在联邦机构施压后，将下架其号称韦戈维（Wegovy）廉价替代品的减肥药。
点击此处下载福克斯新闻应用程序
科顿认可了这一举措，并呼吁未来对其他实体进行类似调查。
“我鼓励进一步调查其他向美国患者暴露危险、未经监管中国API的实体，”科顿写道。
亚历克斯·米勒是福克斯新闻数字版报道美国参议院的记者。
Tom Cotton demands FDA probe into illegal Chinese ingredients in US weight loss drugs
February 13, 2026 11:45am EST / Fox News
FIRST ON FOX: A Senate Republican is demanding the Food and Drug Administration (FDA) investigate whether illegal Chinese ingredients are making their way into weight loss drugs in the United States.
Sen. Tom Cotton, R-Ark., called on FDA Commissioner Martin Makary to probe how far unregulated and illegal Chinese active pharmaceutical ingredients have penetrated the U.S. supply chain — and whether they have ended up in popular weight loss drugs.
“China’s access to America’s pharmaceutical supply chain presents national security risks as well as significant health risks to American patients,” Cotton wrote in a letter to Makary first obtained by Fox News Digital.
JELLY ROLL’S WIFE SAYS WEIGHT LOSS DRUG SENT HER INTO ‘WORST SUICIDAL DEPRESSION’
Sen. Tom Cotton, R-Ark., called on FDA Commissioner Martin Makary to probe just how widespread illegal and unregulated Chinese pharmaceutical ingredients are in the U.S., and how widespread they are in non-FDA regulated weight loss drugs.(Bill Clark/CQ Roll Call, Inc. via Getty Images)
Cotton’s concern follows recent reports from the FDA and Customs and Border Protection (CBP) that between September 2023 and January 2025, authorities intercepted 195 illegal shipments of active pharmaceutical ingredients.
He noted that the ingredients were “likely used in compounded weight loss medications” that entered the U.S. market. Of those shipments, roughly 60 originated from China and Hong Kong.
“It is estimated that as of January 2026, up to 1.5 million American patients could be using unregulated compounded weight loss medications that may contain potentially dangerous ingredients from Chinese manufacturers,” Cotton wrote.
EXAMINING THE NEXT THREAT FROM COMMUNIST CHINA: OUR HEALTHCARE SYSTEM
Americans turn to risky unregulated sellers for GLP-1 weight loss drugs.(iStock)
The ingredients are typically used in compounded versions of GLP-1 weight loss drugs that are marketed as alternatives to FDA-approved medications such as Ozempic and Wegovy.
Earlier this month, the Department of Health and Human Services announced it would refer telehealth company Hims & Hers to the Justice Department for “potential violations of the Federal Food, Drug, and Cosmetic Act” over its planned sale of a compounded, non-FDA-approved weight loss drug.
Makary similarly said the FDA would “take decisive steps to restrict GLP-1 active pharmaceutical ingredients (APIs) intended for use in non-FDA-approved compounded drugs that are being mass-marketed by companies — including Hims & Hers and other compounding pharmacies — as alternatives to FDA-approved drugs.”
FETTERMAN BUCKS DEMOCRATS, SAYS PARTY PUT POLITICS OVER COUNTRY IN DHS SHUTDOWN STANDOFF
The company announced last week that it would remove its weight loss pill, billed as a cheaper alternative to Wegovy, from the market following mounting pressure from federal agencies.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Cotton acknowledged that move and called for similar investigations going forward.
“I encourage further investigations into other entities that expose American patients to dangerous, unregulated Chinese APIs,” Cotton wrote.
Alex Miller is a writer for Fox News Digital covering the U.S. Senate.
发表回复